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Abstract
Introduction: Pluripotent, human stem cells hold tremendous promise as a source of progenitor and terminally
differentiated cells for application in future regenerative therapies. However, such therapies will be dependent
upon the development of novel approaches that can best assess tissue outcomes of pluripotent stem cell-derived
cells and will be essential to better predict their safety and stability following in vivo transplantation.
Methods: In this study we used engineered, human skin equivalents (HSEs) as a platform to characterize fibroblasts
that have been derived from human embryonic stem (hES) cell. We characterized the phenotype and the secretion
profile of two distinct hES-derived cell lines with properties of mesenchymal cells (EDK and H9-MSC) and
compared their biological potential upon induction of differentiation to bone and fat and following their
incorporation into the stromal compartment of engineered, HSEs.
Results: While both EDK and H9-MSC cell lines exhibited similar morphology and mesenchymal cell marker expression,
they demonstrated distinct functional properties when incorporated into the stromal compartment of HSEs. EDK cells
displayed characteristics of dermal fibroblasts that could support epithelial tissue development and enable re-
epithelialization of wounds generated using a 3D tissue model of cutaneous wound healing, which was linked to
elevated production of hepatocyte growth factor (HGF). Lentiviral shRNA-mediated knockdown of HGF resulted in a
dramatic decrease of HGF secretion from EDK cells that led to a marked reduction in their ability to promote keratinocyte
proliferation and re-epithelialization of cutaneous wounds. In contrast, H9-MSCs demonstrated features of mesenchymal
stem cells (MSC) but not those of dermal fibroblasts, as they underwent multilineage differentiation in monolayer culture,
but were unable to support epithelial tissue development and repair and produced significantly lower levels of HGF.
Conclusions: Our findings demonstrate that hES-derived cells could be directed to specified and alternative
mesenchymal cell fates whose function could be distinguished in engineered HSEs. Characterization of hES-derived
mesenchymal cells in 3D, engineered HSEs demonstrates the utility of this tissue platform to predict the functional
properties of hES-derived fibroblasts before their therapeutic transplantation.
Introduction
The use of pluripotent, human stem cells, including human
embryonic stem (hES) cells and human induced pluripo-
tent stem (hiPS) cells, for future therapies provides advan-
tages over more traditional sources of progenitor cells,
such as adult stem cells, due to their ability to give rise to a
variety of differentiated cell types and to their unlimited
expansion potential [1,2]. However, such therapies will be
dependent upon the development of novel approaches that
can best assess tissue outcomes of hES- and hiPS-derived
cells and will be essential to better predict their safety and
stability following in vivo transplantation. One possible
approach would be to use three dimensional (3D),
engineered tissues to monitor the functional outcomes of
hES- and hiPS-derived cells. By providing an in vivo-like
microenvironment that enables progenitor cells to manifest
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their in vivo characteristics in 3D tissue context, tissue
engineering can play an important role in determining the
function, stability, and safety of hES- and hiPS-derived cells
before their future application.
Stromal fibroblasts play a critical role in regulating tis-
sue homeostasis and wound repair through the synthesis
of extracellular matrix proteins and by secreting para-
crine-acting growth factors and cytokines that have a
direct effect on the proliferation and differentiation of
adjacent epithelial tissues [3-6]. Despite the critical
impact of this reciprocal cross-talk between stromal
fibroblasts and epithelial cells on tissue homeostasis, lit-
tle is known about the identity and maturational devel-
opment of the precursor cells that give rise to these
fibroblasts. This incomplete understanding of fibroblast
lineage development is in large part due to the lack of
definitive markers and to their cellular heterogeneity
in vivo that has complicated their isolation, characteriza-
tion, and potential therapeutic applications [7-9].
In light of this, human pluripotent stem cells may
serve as an alternative to adult tissues of more uniform
fibroblasts that may provide more predictable tissue out-
comes upon their therapeutic use. Several previous stu-
dies have demonstrated the derivation of mesenchymal
stem cell (MSC)-like cells from hES cells that can differ-
entiate to bone, fat, and cartilage [10-13], and fibroblast-
like cells that have been used as autogenic feeders to
support the culture of undifferentiated hES cells [14-17].
In our previous work, we have demonstrated that hES
cells give rise to fibroblast-like cells [18]; however, we
have not determined if hES-derived cells can manifest
the functional properties of dermal fibroblasts that can
support the organization and development of 3D skin-
like tissues also known as human skin equivalents
(HSEs) through epithelial-mesenchymal cross-talk. As
the morphogenesis, homoeostasis, and repair of many
tissues depends on interactions between epithelial cells
and their adjacent stromal fibroblasts [3-6], the func-
tional analysis of hES-derived fibroblasts could best be
accomplished in such engineered HSEs that demonstrate
many features of their in vivo counterparts.
In this study, we have characterized two cell lines with
features of MSC lineages (EDK and H9-MSC) that differ
from each other in their production of hepatocyte
growth factor (HGF), a growth factor known to be
secreted by dermal fibroblasts that supports epithelial
development and repair. In monolayer cultures, we
found that EDK and H9-MSCs exhibited considerable
overlap as seen by their mesenchymal morphology and
expression of surface markers characteristic of both
MSCs and dermal fibroblasts. However, EDK cells could
not undergo differentiation to bone and fat and demon-
strated properties similar to stromal fibroblasts that
could support epithelial tissue development and enable
re-epithelialization of HSEs that was linked to the ele-
vated expression and secretion of HGF. In contrast, H9-
MSCs displayed multipotent differentiation capacity
typical of an MSC phenotype [19], but did not support
epithelial tissue development or repair, possible due to a
low level of HGF production. When HGF secretion
from EDK cells was suppressed by shRNA, epithelial
repair was significantly decreased, suggesting that the
regenerative phenotype of EDK cells is mediated, at
least in part, by HGF secretion. HSEs used in our stu-
dies provided a complex tissue microenvironment that
enabled characterization of the functional properties of
hES-derived fibroblasts and provide an important plat-
form to further establish their stability, safety, and effi-
cacy for future therapeutic transplantation.
Materials and methods
Monolayer cell culture of hES cells and directed
differentiation to mesenchymal and fibroblast fates
A H9 hES cell line was maintained in culture as
described [20], on irradiated feeder layers of mouse
embryonic fibroblasts (MEF). EDK cells were prepared
using our previously described protocol [18]. Briefly, we
derived multiple, independent EDK cell lines by first
growing H9 hES cells on MEFs fixed in 4% formalde-
hyde in differentiation medium supplemented with 0.5
nM human BMP-4 (R&D Systems, Minneapolis, MN,
USA) from day four to seven of differentiation. These
EDK cell lines were then propagated first on tissue cul-
ture plastic and then expanded on type I collagen-
coated plates (BD Biosciences, San Jose, CA, USA). EDK
cell lines were then screened by ELISA to determine
their secretion of HGF and KGF and the lines with
highest production of these growth factors were chosen
for further study. H9-MSCs were prepared as previously
described [21]. Briefly, H9 hES cells were grown on irra-
diated feeder layers of MEFs in differentiation medium
for 10 days and then switched to MSC medium (Lonza,
Basel, Switzerland) for four extra days to enrich for
MSC-like cells. Differentiating cells were then fluores-
cence-activated cell sorting (FACS)-sorted for CD73-
positive cells expanded on MSC medium first on tissue
culture plastic and then passaged on type I collagen-
coated plates. Both protocols for cell derivation from H9
hES cells are summarized in (Figure 1a). Control human
dermal fibroblasts (HFF) were derived from newborn
foreskin and grown in DMEM (Invitrogen, Carlsbad,
CA, USA) supplemented with 10% FBS (Hyclone, Logan
UT, USA).
Construction of human skin equivalents and 3D tissue
model of cutaneous wound healing
Engineered 3D HSEs were constructed as previously
described [22] by adding HFF, EDK, or H9-MSCs or no
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cells into type I collagen gels (Organogenesis, Canton,
MA, USA) to a final concentration of 2.5 × 104 cells/ml.
Human keratinocytes (NHK) at a concentration of 5 ×
105 were seeded onto the collagen matrix and tissues
were then maintained submerged in low calcium epider-
mal growth media for two days, for an additional two
days in normal calcium media, and raised to the air-
liquid interface (Organogenesis, Canton, MA, USA). For
the preparation of 3D tissue models of cutaneous
wound healing, HSEs constructed using HFF were
wounded with a 4 mm punch and placed on the surface
of a contracted collagen gel populated with either HFF,
EDK, H9-MSCs, or without cells as previously described
[22,23]. Wounded cultures were maintained at the air-
liquid interface for 72 or 96 hours at 37°C in 7.5% CO2
to monitor re-epithelialization. For quantitative analysis
of wound re-epithelialization, tissue samples were fixed
in 4% neutral-buffered formalin, embedded in paraffin,
Figure 1 Characterization of hES-derived mesenchymal cell lines. (a) Schematic summarizing the two protocols used for generating EDK
and H9-MSC from H9 human embryonic stem (hES) cells. (b) Cellular morphology of human foreskin fibroblasts (HFF), EDK, and H9-MSC using
phase contrast. Bars, 50 μm. (c) Expression of mesenchymal markers vimentin, Thy1, and a-SMA following immunofluorescence staining. Bars, 50
μm. (d) Comparison of surface antigen expression on HFF, EDK, and H9-MSC by flow cytometric analysis. EDK and H9-MSCs express markers
associated with mesenchymal phenotype (positive for expression CD73, CD105, CD44, CD13, CD106, and CD166; negative for expression of
CD45, CD34, and CD31). EDK and H9-MSCs show significant differences in expression of CD146 and CD10 antigens. (HFF, filled grey profile; EDK,
red profile; H9-MSC, black profile).
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and serially sectioned at 8 μm. Histological sections
were stained with H&E, images were captured using a
Nikon Eclipse 80i microscope (Nikon Instruments Inc.,
Melville, NY, USA) equipped with a SPOT RT camera
(Diagnostic Instruments, Sterling Heights, MI, USA) and
analysed using Spot Advanced software (Diagnostic
Instruments, Sterling Heights, MI, USA).
Real-time RT-PCR
Total RNA was extracted from confluent cultures of
EDK, H9-MSC, or HFF cells using RNeasy kit (Qiagen,
Valencia, CA, USA) and cDNA was transcribed with
1 μg RNA using the Quantiscript Reverse Transcriptase
(Qiagen, Valencia, CA, USA). For each real-time
RT-PCR reaction, we used 20 ng of cDNA, 200 nM of
each primer, and 2X SYBRgreen (Applied Biosystems,
Foster City, CA, USA) at a total sample volume of 12.5
μL and samples were run in triplicates on the Bio-Rad
CFX96 Real-Time PCR Detection System according to
manufacturers’ instructions. The relative level of gene
expression was assessed using the 2 -ΔΔCt method and
results are presented as an average of two experiments
and three technical replicates. The following oligonu-
cleotide primer sequences were used: GAPDH-F1: 5’-
tcgacagtcagccgcatcttcttt-3’, GAPDH-R1: 5’-accaaatccgtt
gacctt-3’, HGF-F1: 5’-aggggcactgtcaataccatt-3’, and
HGF-R1: 5’-cgtgaggatactgagaatcccag-3’.
RNAi
The pLKO.1-puro non-target shRNA control vector and
the pLKO.1-puro vector containing shRNA against HGF
(TRCN clone 3310) were purchased from Sigma (Sigma,
MISSION shRNA, St. Louis, MO, USA). Lentiviral parti-
cles were generated in 293FT cells using ViraPower™
Lentiviral Expression System (Invitrogen, Carlsbad, CA,
USA) according to manufacturer protocol. Knockdown
viruses were titered using an end-point dilution assay
and cell lines were infected with lentiviruses at a multi-
plicity of infection of one. Stable cell lines were selected
with puromycin (2 μg/ml).
ELISA
Tissue culture supernatants were harvested and pro-
cessed using commercial DuoSet HGF ELISA kit (R&D
Systems, Minneapolis, MN, USA). Media was assayed in
triplicates from at least three independent samples. For
monolayer cultures, the values were normalized accord-
ing to cell numbers counted in the respective cultures at
the time of supernatant harvesting and expressed in pg/
ml per 104 cells.
Antibody-based cytokine array
HFF, EDK, or H9-MSCs 106 cells were seeded onto
100 mm tissue culture plates and grown in 10 ml of
tissue culture medium. Forty-eight hours before the ana-
lysis, cultures were maintained in 5 ml of tissue culture
medium. Tissue culture supernatants were harvested and
the supernatants from the plates containing equal cell
numbers were processed using commercial Proteome
Profiler Human Angiogenesis Antibody Array (R&D Sys-
tems, Minneapolis, MN, USA) according to manufacturer
protocol. Histogram profiles for select analytes were gen-
erated by quantifying the mean spot pixel densities from
the array membrane using ImageJ software (U. S.
National Institutes of Health, Bethesda, Maryland, USA).
Morphologic, immunofluorescent, and
immunohistochemical analysis of human skin equivalents
HFF, EDK, or H9-MSCs were grown to confluence on
glass or type I collagen-coated coverslips, fixed in 4%
paraformaldehyde, and permeabilized using 0.1% triton
X-100. Cells were stained using primary monoclonal
antibodies directed against vimentin (Abcam, Cam-
bridge, MA, USA), a-SMA (Chemicon, Temecula, CA,
USA), Thy-1 (Calbiochem, San Diego, CA, USA) fol-
lowed by Alexa 488-conjugated goat anti-mouse second-
ary antibodies (Invitrogen, Carlsbad, CA, USA) for one
hour. For frozen section analysis, tissues were frozen in
O.C.T. compound (Sakura Finetek USA, Torrance, CA,
USA) and 8 μm sections were fixed in 4% paraformalde-
hyde and immunostained using primary antibodies
directed against K1/10 (Abcam, Cambridge, MA, USA)
followed by Alexa 594-conjugated goat anti-mouse sec-
ondary antibodies (Invitrogen, Carlsbad, CA, USA). For
morphologic analysis, H&E staining was performed on
paraffin-embedded tissues sectioned at 8 μm thickness.
For proliferation analysis, HSEs were labeled with a six-
hour pulse of BrdU (Sigma, St. Louis, MO, USA) at a
final concentration of 10 μM. Immunohistochemical
staining was performed on paraffin-embedded tissues
sectioned at 8 μm thickness using monoclonal antibo-
dies against BrdU (Roche, Indianapolis, IN, USA) and
Vectastain ABC (peroxidase) kit (Vector Labs, Burlin-
game, CA, USA). The number of BrdU-positive cells
was determined and expressed as a percentage of total
cells in the basal layer. Two independent experiments
with a minimum of three observations for each condi-
tion were analyzed.
Flow cytometric analysis of hES-derived cell lines
HFF, EDK, or H9-MSCs were grown to confluence,
trypsinized, pelleted, and resuspended in 2% FBS in PBS
solution. Cell suspensions were mixed with 15 μl of PE-
conjugated anti -CD73, -CD10, -CD13, -CD105,
-CD106, -CD166, -CD44, -CD34, -CD45, -CD31 or iso-
type control-IgG1k (BD Pharmingen, San Jose, CA,
USA), and flow cytometric analysis was performed using
a FACSCalibur (BD Biosciences, San Jose, CA, USA)
Shamis et al. Stem Cell Research & Therapy 2011, 2:10
http://stemcellres.com/content/2/1/10
Page 4 of 12
and analyzed using CellQuest (BD Biosciences, San Jose,
CA, USA) and Summit V4.3 software (Dako, Carpen-
teria, CA, USA).
Osteogenic and adipogenic differentiation assays
To induce osteogenesis HFF, EDK, or H9-MSCs were
grown to confluence in the presence of 100 nM dexa-
methasone, 0.05 mM ascorbic acid, and 10 mM-glycero-
phosphate (all from Sigma, St. Louis, MO, USA) in
DMEM supplemented with 1% of non-essential amino-
acids (Invitrogen, Carlsbad, CA, USA), and 10% FBS.
After 28 days, cultures were fixed in 1% formaldehyde,
and stained for 10 minutes with alizarin red solution
(Sigma, St. Louis, MO, USA) to determine calcium
deposition, and staining was quantified spectrophotome-
trically (A550) after solubilization with 10% CPC (Sigma,
St. Louis, MO, USA). To induce adipogenesis HFF,
EDK, or H9-MSCs were grown to confluence in 24-well
plates in the presence of 1 μM dexamethasone, 50 μM
indomethacin, 5 μg/ml insulin, and 0.5 mM 3-isobutyl-
1-methyl-xanthine (all from Sigma, St. Louis, MO, USA)
in DMEM supplemented with 1% of non-essential
amino-acids, and 10% FBS. After 28 days, cultures were
fixed in 4% formalin and stained with oil red O solution
(Sigma, St. Louis, MO, USA) for 30 minutes to visualize
oil droplets, and staining was quantified spectrophoto-
metrically (A500) after solubilisation with isopropanol.
All results are presented as mean +/- standard deviation
(SD) of three experiments and three technical replicates.
Statistical analysis
Data are expressed as mean ± SD of at least three inde-
pendent samples. Statistical comparisons between groups
were performed with a two-tailed Student’s t-test,
*P ≤ 0.05 and **P ≤ 0.01 was considered significant.
Results
EDK and H9-MSC generated from hES cells demonstrate
morphologic and phenotypic characteristics of
mesenchymal cells
We generated two populations of mesenchymal cells (EDK
and H9-MSC) from hES cells using previously established
protocols as shown schematically (Figure 1a). EDK cells
were derived using a differentiation protocol that we had
previously established to generate fibroblast-like cells from
H9 hES cells [18]. To ensure the fibroblast-like phenotype
of EDK cells, several cell lines were derived from hES-cells
using the same differentiation conditions and were
screened for the secretion of paracrine factors known to
be secreted at high levels in dermal fibroblasts keratinocyte
growth factor (KGF) and hepatocyte growth factor (HGF);
data not shown) [5,6]. Only EDK cell lines secreting ele-
vated levels of KGF and HGF were selected for further
study. H9-MSCs were derived using an alternative
differentiation protocol that has previously been shown to
generate MSC-like cells from H9 hES cells based on
FACS-isolation of CD73-positive cell subpopulations [21].
Both EDK and H9-MSC populations showed similar fibro-
blast morphology and expression of Thy-1 and vimentin
by immunohistochemical staining that were similar to that
seen in dermal HFF, while a-SMA-positive cells were
observed more frequently in EDK cultures than in either
H9-MSC or HFF (Figures 1b and 1c). Surface marker pro-
filing of EDK and H9-MSCs was performed by flow cyto-
metric analysis and compared with the profile generated
for HFFs. EDK and H9-MSC lines presented a similar pro-
file of surface antigen expression characteristic of
mesenchymal cells. Both hES-derived cell lines expressed
CD73, CD105, CD106, CD44, CD166, CD13, and CD146
and lacked expression of hematopoietic and endothelial
lineage markers CD45, CD34, and CD31 (Figure 1d). The
intensity of fluorescent labelling and the distribution of
labelled cells were similar for CD73, CD105, CD106,
CD44, CD166, and CD13 when EDK and H9-MSC were
compared. However, expression of CD10 was significantly
higher, while CD146 was lower in the EDK cell line when
compared with H9-MSCs. This elevated expression of
CD10 and reduced expression of CD146 was also seen in
HFFs, suggesting a fibroblast-like phenotype for EDK cells.
These findings indicated that while both hES-derived cell
populations exhibited characteristic mesenchymal surface
markers, differences in their CD profile suggested differ-
ences in their biological potential.
H9-MSCs undergo differentiation to osteogenic and
adipogenic fates, while EDK cells do not show
multilineage differentiation potential
To assess the biological potential of the EDK and
H9-MSC populations, we performed osteogenic and adi-
pogenic differentiation assays. After four weeks under
differentiation conditions, H9-MSCs cultures contained
calcium deposits as detected by alizarin red (Figures 2a
and 2b), and oil red-O-positive lipid droplets (Figures 2c
and 2d). In contrast, EDK did not show this differentia-
tion potential as cells did not form bone or fat (Figure 2).
These findings demonstrated that EDK and H9-MSC cell
lines had divergent cell fates, as seen by their potential to
form osteoblasts and adipocytes. Although H9-MSCs
manifested properties of MSC-like progenitors, absence
of multilineage differentiation potential in EDK cells sug-
gested that these cells may have underwent developmen-
tal restriction to fibroblast lineage fate [10,24].
EDK cells demonstrate fibroblast function characterized
by their support of the normal development of 3D
human skin equivalents
As the paracrine cross-talk between fibroblasts and epithe-
lial cells is required for the development of stratified
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epithelial tissue, we next incorporated EDK or H9-MSC
into HSEs as a functional assay for their capacity to sup-
port normal skin development. EDK or H9-MSC were
embedded into collagen gels and allowed to contract the
gel for seven days. Normal NHK were then seeded onto
the surface of collagen gels, and tissues were grown at an
air-liquid interface for an additional seven days to compare
their capacity to form a multi-layered epithelium. HSEs
constructed with HFFs or no cells embedded into collagen
gels served as positive and negative controls, respectively.
Morphological analysis revealed that EDK cells promoted
epithelial tissue development in a manner similar to HFFs,
while tissues grown in the presence of H9-MSC did
not support normalization of the overlying epithelium
(Figure 3a). HSEs constructed with EDK cells developed a
fully-stratified, multi-layered epithelium that was well-dif-
ferentiated and demonstrated tissue architecture similar to
epithelial tissues generated with control HFF cells. In con-
trast, tissues populated with H9-MSCs generated a thin
and poorly-developed epithelium that was similar to tis-
sues generated in the absence of any fibroblast support.
The characteristic supra-basal distribution of keratin 1/10,
a marker of differentiated keratinocytes, in both EDK and
HFF containing tissues confirmed the capacity of EDK
cells to promote normal epithelial morphogenesis and dif-
ferentiation (Figure 3b).
As efficient development of HSEs is dependent on
paracrine support from connective tissue fibroblasts, as
has been previously shown for mature fibroblasts [3-6],
we used a panel of growth factors and cytokines known
to function as mediators of epithelial cell growth to com-
pare the secretory profile of EDK, H9-MSC, and HFF
cells. Supernatants from EDK, H9-MSC, and control HFF
cultures containing equal cell numbers were harvested
and assayed using an antibody-based cytokine array
(Figures 3c and 3d). This analysis revealed that EDK cells
produced elevated levels of epidermal growth factor
(EGF), granulocyte-macrophage colony-stimulating fac-
tor (GM-CSF), platelet-derived growth factor-AA
(PDGF-AA), KGF, and HGF when compared with both
H9-MSC and HFF cells. In contrast, H9-MSC produced
higher levels of IL-8, monocyte chemotactic protein-1
(MCP-1), and PDGF-AB/BB than EDK or HFF cells.
Notably, the level of HGF, known to be essential for skin
development and repair [5,6] was elevated in both EDK
and HFF cells but not in H9-MSCs. Using real-time PCR
and ELISA, we detected a 10-fold elevation of HGF
expression and secretion in EDK cells compared with
HFF and a 100-fold elevation when compared with H9-
MSC (Figures 3e and 3f). These findings indicated that
the biological potential of hES-derived mesenchymal cells
was not uniform. Although H9-MSCs could differentiate
to osteogenic and adipogenic lineages, this cell line did
not provide the paracrine support needed for epithelial
development or maturation. In contrast, EDK cells
demonstrated properties similar to dermal fibroblasts
(HFF) based on their capacity to direct epithelial mor-
phogenesis in an in vivo-like tissue environment.
Figure 2 Adipogenic and osteogenic differentiation of hES-derived mesenchymal cells. (a) Analysis of osteogenic activity of EDK, H9-MSC,
and human foreskin fibroblasts (HFF). Osteogenic differentiation was induced using the b-glycerophosphate method, after four weeks of
differentiation, calcium deposition was stained with alzarin red. Bars, 50 μm. (b) Quantification of alizarin red staining (t-test: **P < 0.01). Results
are expressed as the mean +/- standard deviation (SD) of three independent experiments and three technical replicates per experiment. (c)
Analysis of adipogenic activity of EDK, H9-MSC, and HFF. Adipogenic differentiation was induced using the 3-isobutyl-1-methylxanthine (IBMX)
method, and after four weeks of differentiation the lipid vesicles were stained with oil red O. Bars, 50 μm. (d) Quantification of oil red O staining
(t-test: **P < 0.01). Results are expressed as the mean +/- SD of three experiments and three technical replicates per experiment.
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EDK cells accelerate the rate of wound healing in 3D
human skin equivalents linked to their HGF production
We used our previously-developed 3D tissue model of
cutaneous wound healing [22,23] to determine whether
EDK and H9-MSCs could also modulate the re-epithe-
lialization of wounded epithelia. To test this, HSEs con-
structed using HFF were wounded with a 4 mm punch
and placed on the surface of a contracted collagen gel
populated with either HFF, EDK, H9-MSCs, or without
cells (see schematic in Figure 4a). HFFs have previously
been shown to enable complete re-epithelialization
[23,25] and serve as a positive control, while collagen
gels generated without any cells were used as a negative
control for re-epithelialization. Ninety-six hours after
wounding, the wound bed was partially or completely
covered by a migrating epithelial tongue towards the
Figure 3 EDK cells but not H9-MSC promote epidermal morphogenesis in HSE tissues. (a): Tissue morphology of human skin-equivalent
(HSE) tissues constructed using human foreskin fibroblasts (HFF), EDK, H9-MSC, or without cells as analyzed by H&E staining. (b) The expression
pattern of the epidermal differentiation marker keratin 1/10 was analyzed by immunofluorescence (red). Bars, 50 μm. (c) Comparison of the
secretory profile of EDK, H9-MSC, and HFF cells by antibody-based cytokine array (d) Histogram profiles generated by quantifying the mean spot
pixel densities by ImageJ from the array membrane shown above. The data are presented as percentages of the respective positive controls. (e)
Hepatocyte growth factor (HGF) mRNA expression in HFF, EDK, and H9-MSC by real-time RT-PCR. Data are normalized to GAPDH, and all results
are expressed as the mean +/- standard deviation (SD) of three experiments and three technical replicates per experiment. (f) Levels of HGF in
supernatants from HFF, EDK, and H9-MSC monolayer cultures by ELISA. Data are normalized per 104 cells and all results are expressed as the
mean +/- SD of three experiments and three technical replicates per experiment.
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central area of the wound bed and by a more stratified
epithelium toward the wound margins (Figure 4b). The
degree of re-epithelialization following wounding was
measured by calculating the distance separating the two
epithelial tongues and was normalized to the distance
between the initial wound margins and expressed gra-
phically as the percentage of wound closure (Figure 4c).
In general, EDK cells showed nearly complete or com-
plete wound closure that was similar to tissues in which
HFF were incorporated (HFF = 86 ± 12% and EDK = 99
± 1.6%). In contrast, H9-MSCs-harboring tissues and
the tissues constructed without any fibroblast support
showed a significantly lower degree of re-epithelializa-
tion compared with HFF (H9-MSC = 39 ± 5.5% and no
cells = 17 ± 5%, t-test: P = 0.003 and P = 0.0007, respec-
tively; Figure 4c). To test whether degree of wound re-
epithelialization was linked to HGF levels, HGF concen-
trations in supernatants from wounded HSEs were mea-
sured by ELISA. Quantification of HGF production
revealed that both HFF- and EDK-containing tissues
produced significantly higher levels of HGF (5-fold and
50-fold higher, respectively) than H9-MSC-containing
tissues or in tissues without cells in their stroma (Figure
4d). These results imply that HGF-mediated paracrine
signalling was responsible, at least in part, for the
wound re-epithelialization mediated by EDK cells.
Suppression of HGF production impairs the ability of EDK
cells to promote wound healing in 3D human skin
equivalents
To confirm that HGF secretion is necessary to optimally
direct the re-epithelialization of cutaneous wound
Figure 4 EDK cells accelerate re-epithelialization of wounded HSEs. (a) Schematic of 3D tissue model of wound re-epithelialization. In step
1, a full-thickness wound is generated by excising a human skin-equivalent (HSE). In step 2, the wounded HSE is placed on a second, contracted
collagen gel populated with EDK, H9-MSC, human foreskin fibroblasts (HFF), or constructed without cells. In step 3, keratinocytes (NHK) undergo
migration to close the wound gap and restored epithelial integrity. The far right panel is an image of six-well insert containing HSE 96 hours
after wounding. (b) Representative morphology of wounded tissues constructed with HFF, EDK, H9-MSC, or without cells 96 hours after
wounding (black arrows demarcate the initial wound edges). Bars, 200 μm. (c) EDK showed a rate of wound closure similar to tissues in which
HFF were incorporated. The degree of re-epithelialization was significantly lower in H9-MSC and no cells-containing tissues as compared with
HFF (t-test: **P < 0.01). (d) Levels of hepatocyte growth factor (HGF) in supernatants of wounded tissues 96 hours after wounding as measured
by ELISA. HFF- and EDK-containing tissues produced higher levels of HGF as compared with H9-MSC-containing tissues or tissues constructed
without cells. All results are presented as the mean +/- standard deviation of three independent experiments and three technical replicates.
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mediated by EDK cells, levels of HGF secreted from
EDK cells were significantly reduced by introducing a
lentiviral shRNA construct that targeted HGF mRNA
(shHGF). Efficiency of shHGF in EDK cells was mea-
sured relative to a scrambled, shRNA control (shScram)
by ELISA and showed a 95% reduction in secretion of
HGF from EDK cells (Figure 5a, top panel). This shHGF
lentiviral construct did not alter secretion of other
growth factors, such as KGF (Figure 5a, lower panel).
The effect of decreased HGF secretion on the capacity
of EDK cells to promote re-epithelialization of wounded
HSEs was examined by incorporating EDK-shHGF and
EDK-shScram into 3D tissue model of cutaneous wound
repair. Tissue morphology and the degree of re-epithe-
lialization following wounding were analysed 72 hours
after wounding. Tissues constructed using EDK-shHGF
cells showed a significantly lower degree of re-epithelia-
lization compared with EDK-shScram (EDK-shScram =
33 ± 9% vs. EDK-shHGF = 11.6 ± 5.8%, t-test: P =
0.017; Figures 5b and 5c). HGF levels in supernatants
from wounded HSEs were measured by ELISA and
showed roughly 85% reduction of HGF levels in cultures
containing EDK-shHGF (Figure 5d). To further charac-
terize the phenotype of wounded epithelial tissues in the
presence of EDK-shHGF and control EDK-shScram, we
assayed proliferation of keratinocytes in the basal layer
of wound margins using a BrdU-incorporation assay
(Figure 5e). Tissues harboring EDK-shHGF demon-
strated a significantly lower percentage of proliferating
basal keratinocytes compared with EDK-shScram (EDK-
shScram = 10 ± 3.5% and EDK-shHGF = 4.4 ± 1.8%,
t-test: P = 0.004; Figure 4f). These results support the
known function of HGF as a mediator of epithelial cell
proliferation in restoring epithelial integrity following
wounding [6]. This suggested that hES-derived EDK
cells stimulated wound re-epithelialization by providing
paracrine signals, such as HGF, that is needed to direct
the repair of a cutaneous wound.
Discussion
Our comparative characterization of two hES-derived cell
lines (EDK and H9-MSC) that were differentiated under
different conditions has revealed that both cell lines exhib-
ited similar morphology and cell surface marker expression
indicative of a mesenchymal phenotype [19]. However,
although EDK cells showed some phenotypic overlap with
H9-MSC and adult MSCs [19] in two dimensional (2D)
monolayer culture, their functional properties in engi-
neered 3D tissues and the absence of the multilineage dif-
ferentiation potential seen in H9-MSC provided evidence
of their fibroblast lineage commitment. Thus, we have
demonstrated that engineered, 3D tissues can be used as a
sensitive assay to characterize the biological potency of
hES-derived fibroblasts. Incorporation of hES-derived cells
into tissues that mimic their in vivo counterparts enables a
more complete determination of their lineage commitment
and phenotype than conventional, monolayer cultures. We
have previously generated a fibroblast-like cell line that
partially supported a 3D tissue whose surface cells were
hES-derived cells with ectodermal features [18]. We now
extend those studies using an hES-derived cell line that
produced elevated levels of HGF to provide paracrine sup-
port for tissue development and repair that mimics the
functional features of dermal fibroblasts. We have shown
the suppression of HGF production in EDK cells is linked
to a significant decrease in epithelial proliferation and
repair, suggesting that these cells mediate epithelial tissue
phenotype through a paracrine support. In contrast, a hES-
derived cell line that manifests multilineage differentiation,
but very low HGF levels (H9-MSC) was unable to support
epithelial tissue development and repair.
Despite the critical impact of fibroblasts on tissue
morphogenesis, homeostasis, and repair, gaps in our
understanding of fibroblast lineage development has
made the identification and reproducible isolation of
specific fibroblast populations particularly challenging
[8,9]. In this light, we expect that our findings will help
address a central challenge facing clinical application of
cells with properties of dermal fibroblasts for regenera-
tive medicine by developing an efficient approach to
reproducibly procure these cells from pluripotent stem
cells, in a way that offers predictable and effective tissue
outcomes upon their therapeutic use [1,2].
In previous studies, MSC-like cells expressing
a-smooth muscle actin (a-SMA) have been derived
from hES cells [26,27] and fibroblast-like cells isolated
from hES cells have been used as autogenic feeders to
support the culture of undifferentiated hES cells [14-17].
In addition, we have found that surface marker profile
of EDK and H9-MSC cell lines is similar to those
expressed on MSCs previously derived from hES cells
using alternative differentiation conditions to those
described in our study [10-13]. However, MSC-like cells
derived in these previous studies were not grown in 3D
tissue microenvironments that could provide a more
complete functional characterization of their identity as
fibroblasts. As the use of cell surface markers to distin-
guish MSCs from cells restricted to fibroblast lineage
fate is limited, tissue-based, functional readouts are
essential to predict the potency of hES-derived cells dif-
ferentiated into fibroblast lineages [24,28]. As it is possi-
ble that EDK cells represent a heterogeneous mixture of
fibroblasts and a smaller number of cells that retain
MSC-like features, their future therapeutic use may
require further characterization of fibroblast subpopula-
tions. This approach has recently been demonstrated to
improve the specificity of MSCs differentiated from hES
cells in ways that can select for reproducible and
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clinically-applicable cells [11]. In addition, it remains
unclear what factors may direct the differentiation of
EDK cells to a fibroblast fate.
Transplantation of adult-derived MSCs has previously
been shown to promote tissue regeneration and to
improve wound repair in vivo [29-32]. Increasing
evidence suggests that this repair potential is linked to
the ability of MSCs to secrete paracrine-acting factors
that can induce changes in their tissue microenviron-
ment to guide healing [33,34]. We found that EDK cells
secreted a broad repertoire of growth factors and cyto-
kines linked to a variety of paracrine-mediated tissue
Figure 5 Suppression of HGF production impairs EDK-mediated re-epithelialization of wounded HSEs. (a) Efficiency of shRNA knockdown
of hepatocyte growth factor (shHGF) in EDK cells relative to a scrambled, shRNA control (shScram) as measured by ELISA. Secretion of
hepatocyte growth factor (HGF; top panel) was reduced 95% relative to shScram (t-test: **P < 0.01), secretion of KGF (lower panel) was not
affected by shHGF. Data are normalized to shScram and all results are expressed as the mean +/- standard deviation (SD) of three experiments
and three technical replicates per experiment. (b) Representative morphology of wounded tissues constructed with EDK-shHGF and EDK-
shScram cells 72 hours after wounding (black arrows demarcate the initial wound edges; white arrows demarcate the tip of epithelial tongues).
Bars, 200 μm. (c) The degree of re-epithelialization was significantly lower in tissues containing EDK-shHGF cells as compared with EDK-shScram
(t-test: **P < 0.01). (d) Relative levels of HGF in supernatants of wounded tissues 72 hours after wounding as measured by ELISA. Tissues
containing EDK-shHGF cells produced significantly lower levels of HGF as compared with EDK-shScram (t-test: **P < 0.01). (e) Proliferation of
basal keratinocytes in tissues containing EDK-shHGF and EDK-shScram cells was analyzed using immunoperoxidase staining with anti-BrdU
antibody 72 hours after wounding (black arrows demarcate the initial wound edges; white arrows demarcate the BrdU-positive cells). (f)
Quantification of BrdU-positive basal keratinocytes. Tissues containing EDK-shHGF demonstrated significantly lower percentage of proliferating
basal keratinocytes compared with EDK-shScram (t-test: **P < 0.01). Bars, 100 μm. All results are presented as the mean +/- SD of three
independent experiments and three technical replicates.
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responses, including stimulatory, paracrine factors
known to accelerate the healing of epithelial wounds.
Specifically, we found that this augmented re-epitheliali-
zation of wounded keratinocytes was linked to the pro-
duction of HGF by EDK cells, as the diminished
production of this growth factor upon shRNA infection
significantly decreased tissue re-epithelialization. As
HGF is known to be induced in stromal cells in
response to injury [5,6], directed differentiation of hES-
derived fibroblasts may allow these cells to be adapted
for cell therapy and cutaneous regeneration. Beyond
this, a decline in fibroblast numbers or function has
been implicated in both skin aging and cancer develop-
ment, because the age-related accumulation of senescent
fibroblasts is thought to create a microenvironment that
promotes squamous cell carcinoma progression [35-37].
As restoration of growth factor production in fibroblasts
may decrease cancer risk and sustain tissue homeostasis,
the development of future cell-based treatments using
hES-derived fibroblasts can potentially augment repair
and improve overall tissue health. We expect that our
findings will enable future studies aimed at clarifying
factors regulating fibroblast development and will help
identify progenitor cells that give rise to these cells in
human skin and other tissues.
Conclusions
A central challenge that must be overcome before thera-
peutic application of hES-derived cells is the develop-
ment of reliable and sensitive methods to evaluate their
safety and efficacy [1,2]. Although hES cells can undergo
directed differentiation to numerous cell types, progress
towards their clinical application has been limited by
the lack of tools and platforms to evaluate their stability
in an in vivo-like tissue context. It is therefore critical to
fully-characterize the properties of differentiated cells
derived from hES cells by developing engineered, pre-
clinical tissue models that will better predict their beha-
vior following future therapeutic transplantation to
humans. As we have shown that fibroblasts derived
from hES cells support the normal development of
HSEs, our study is an important step towards determin-
ing the biological potency of clinically-relevant, func-
tional cell types derived from hES cells.
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